The role of Contrast-Enhanced Spectral Mammography (CESM) in the diagnostic process of breast cancer: can it improve specificity of first-line examinations and therefore reduce the suspicious lesions that undergo vacuum assisted breast biopsy (VABB)?
When routine breast scans show an unusual spot, doctors often recommend a needle biopsy to test the tissue. While biopsies are safe, waiting for results can be stressful, and the procedure can cause bruising or soreness. Many of these spots turn out to be completely harmless. This trial investigates a new technique called Contrast-Enhanced Spectral Mammography (CESM). It works like a normal mammogram, but uses a special dye called Ultravist injected into a vein. Cancerous tissue absorbs dye differently from healthy tissue, making it easier to spot. Researchers want to see if CESM is accurate enough to show when a breast change is definitely harmless. If it is, doctors might use these scans in the future to safely rule out cancer, sparing women from having unnecessary biopsies.
At a glance
What is this study about?
If a routine mammogram or breast check shows a small lump or unusual change, doctors usually need to take a closer look. Currently, the standard next step is often a vacuum-assisted breast biopsy (VABB). This involves numbing the breast and using a small needle to remove tiny samples of tissue. Although this is very safe and reliable, it can cause soreness, bruising, and a lot of worry. In many cases, the final results show that the lump was non-cancerous all along.
This study explores whether an advanced type of mammogram can give doctors clear answers without needing a needle biopsy straight away. The scan is called Contrast-Enhanced Spectral Mammography (CESM). Just before the X-ray, you receive an injection of an iodine-based dye called Ultravist into a vein in your arm. Because abnormal areas often have a higher blood supply, they take up the dye and show up brightly on the images.
By comparing these detailed dye-enhanced scans against standard biopsy and surgery results, researchers hope to confirm how trustworthy the scan is. The main goal is to prove whether a clear CESM scan reliably means there is no cancer present.
If the study is successful, it could change how breast clinics investigate unusual lumps across the NHS and worldwide. In the future, many women might be able to have this quick scan instead of a biopsy, saving time, reducing anxiety, and avoiding invasive procedures.
Key takeaways
- Tests an advanced mammogram that uses a special dye (Ultravist) to highlight breast tissue.
- Aims to find out if this scan can safely rule out cancer and reduce the need for needle biopsies.
- Open to women aged 18 and over who have a suspicious breast spot needing further tests.
- Participants will still receive their standard NHS care, including any planned biopsy or surgery.
- Taking part is voluntary and you can stop at any time without affecting your treatment.
Who may be eligible?
This trial is open to women aged 18 and older who have an unusual breast change or lump that needs further testing.
To be considered, your clinical team must have already decided that your breast change needs an assessment, such as a vacuum-assisted biopsy or surgery, as part of your standard care.
Because the scan uses an iodine dye, this study may not be suitable for people with severe kidney problems, thyroid conditions, or those who have had an allergic reaction to X-ray dyes in the past. Your care team will review your medical history to make sure taking part is safe for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am a woman aged 18 or older.
- I have been told I have a breast spot or lesion that needs further testing.
- My doctor has recommended a needle biopsy or further examination.
- I do not have a known allergy to iodine-based X-ray dyes.
- I do not have severe kidney problems that prevent me from having contrast dye.
What does participation involve?
Taking part in this study takes place at the hospital breast clinic alongside your planned medical care. You will have a contrast-enhanced mammogram scheduled around the time of your standard tests.
During the appointment, a nurse will place a small cannula (a soft plastic tube) into a vein in your arm to inject the Ultravist dye. A few minutes later, you will have standard mammogram images taken while standing up. The dye might cause a warm, flushing feeling or a metallic taste, but this passes very quickly.
After the scan, you will continue with your scheduled care, which may include your planned breast biopsy or surgery. Researchers will then compare the pictures from your dye-enhanced mammogram with the lab results from your biopsy or surgery. You will not need extra treatment visits beyond your standard NHS care and short-term scan follow-ups.
Potential risks and benefits
Locations (1)
- —UnverifiedItaly
Common questions
Will taking part replace my planned biopsy?
No. Because this is a research study, you will still have your standard biopsy or planned surgery so your doctors can be completely certain about your diagnosis.
What does the dye injection feel like?
Most people feel a brief warm sensation spreading through their body, and some notice a mild metallic taste. These feelings are normal and usually fade within a minute or two.
Is the contrast dye safe?
Ultravist is a routinely used hospital dye with a strong safety record. Serious reactions are rare, and the clinical team is fully trained to manage any side effects.
Does the scan take longer than a normal mammogram?
It takes only a few minutes longer, mainly to set up the small drip in your arm and inject the contrast dye before taking the images.
Can I change my mind after agreeing to take part?
Yes. Joining the trial is entirely voluntary. You can withdraw at any time without giving a reason, and your medical care will continue as normal.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.